Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 7/20 | 0.51 |
| ▸ | CNR2 | P34972 | 7/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.43 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.43 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25346873 | 1.00 | CNR1 (0.51) | CNR1CNR2PTPN1PTPN2PTPN6 | |
| SCHEMBL30521967 | 0.90 | CNR1 (0.43) | CNR1CNR2PTPN1PTPN2PTPN6 | |
| SCHEMBL25346065 | 0.90 | CNR1 (0.43) | CNR1CNR2PTPN1PTPN2PTPN6 | |
| SCHEMBL9804713 | 0.87 | CNR1 (0.55) | CNR1CNR2PTGS2CYP3A4 | |
| SCHEMBL25345032 | 0.84 | PTGS2 (0.49) | PTGS2CYP3A4 | |
| SCHEMBL10869869 | 0.84 | CNR1 (0.51) | CNR1CNR2PTPN1PTPN2PTPN6 | |
| SCHEMBL25345188 | 0.83 | PTPN1 (0.59) | PTPN1PTPN2PTPN6 | |
| SCHEMBL30521971 | 0.83 | PTPN1 (0.59) | PTPN1PTPN2PTPN6 | |
| SCHEMBL25346311 | 0.83 | CNR1 (0.52) | CNR1CNR2PTPN1PTPN2PTPN6 | |
| SCHEMBL30521966 | 0.83 | CNR1 (0.52) | CNR1CNR2PTPN1PTPN2PTPN6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116568291-A | Substituted aromatic compounds and pharmaceutical compositions thereof | 殷格纽制药有限公司 | 2023-08-08 | — | — | CN | claimed |
| US-20240043372-A1 | SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | PHARMACEUTIQUE INGENEW INC. (CA) | 2024-02-08 | — | — | US | disclosed |
| CN-116568291-A | Substituted aromatic compounds and pharmaceutical compositions thereof | 殷格纽制药有限公司 | 2023-08-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240043372-A1 | SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | NR1H4, NR1H2, NR1H3 | CNR1 8/4885CNR2 14/4885PTPN1 2432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.